Genenta Science S.p.A. (GNTA)
$0.72-5.26%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $14M
- Beta
- 0.76
- P/E (TTM)
- -1.95
- Short % float
- 0.79%
- Days to cover
- 1.6
- SI change
- -7.4%
- 1W
- -7.69%
- 1M
- -13.25%
- vs SPY 1W
- -8.11%
- vs SPY 1M
- -15.31%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 13
- VALUE
- 11
- GROWTH
- 43
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-22.1%
REV YoY-
ROE-36.8%
EPS YoY-
ROA-19.6%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-1.95
P/E FWD-
SECTOR PE18.08
INDUSTRY PE6.89
P/B0.63
P/FCF-
EV/EBITDA-2.46
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E34.81
ALTMAN Z-
CURR RATIO14.16
ND/EBITDA-
BETA0.76
Company news
FAQ
- What is LOPJLB’s current signal on GNTA?
- LOPJLB’s latest quantitative signal on Genenta Science S.p.A. (GNTA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is GNTA in?
- Genenta Science S.p.A. (GNTA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Genenta Science S.p.A. (GNTA) do?
- Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.